Cargando…

The Gut Microbiota of Critically Ill Patients With COVID-19

The SARS-CoV-2-associated COVID-19 pandemic has shaken the global healthcare system. Although the best-known symptoms are dry cough and pneumonia, viral RNA has been detected in the stool and about half of COVID-19 patients exhibit gastrointestinal upset. In this scenario, special attention is being...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaibani, Paolo, D’Amico, Federica, Bartoletti, Michele, Lombardo, Donatella, Rampelli, Simone, Fornaro, Giacomo, Coladonato, Simona, Siniscalchi, Antonio, Re, Maria Carla, Viale, Pierluigi, Brigidi, Patrizia, Turroni, Silvia, Giannella, Maddalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276076/ https://www.ncbi.nlm.nih.gov/pubmed/34268136 http://dx.doi.org/10.3389/fcimb.2021.670424

Ejemplares similares

The Gut Microbiota of an Individual Varies With Intercontinental Four-Month Stay Between Italy and Nigeria: A Pilot Study
por: Afolayan, Ayorinde O., et al.
Publicado: (2021)

Gut, oral, and nasopharyngeal microbiota dynamics in the clinical course of hospitalized infants with respiratory syncytial virus bronchiolitis
por: Roggiani, Sara, et al.
Publicado: (2023)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study
por: Pascale, Renato, et al.
Publicado: (2021)

Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives
por: Barone, Monica, et al.
Publicado: (2021)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
por: Cojutti, Pier Giorgio, et al.
Publicado: (2022)

The Rootstock Regulates Microbiome Diversity in Root and Rhizosphere Compartments of Vitis vinifera Cultivar Lambrusco
por: D’Amico, Federica, et al.
Publicado: (2018)

The lower respiratory tract microbiome of critically ill patients with COVID-19
por: Gaibani, Paolo, et al.
Publicado: (2021)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
por: Gaibani, Paolo, et al.
Publicado: (2021)

Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context
por: Barone, Monica, et al.
Publicado: (2019)

Gut microbiome–micronutrient interaction: The key to controlling the bioavailability of minerals and vitamins?
por: Barone, Monica, et al.
Publicado: (2022)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
por: Gatti, Milo, et al.
Publicado: (2022)

Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome
por: D’Amico, Federica, et al.
Publicado: (2021)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

Make It Less difficile: Understanding Genetic Evolution and Global Spread of Clostridioides difficile
por: Mengoli, Mariachiara, et al.
Publicado: (2022)

Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
por: Conti, Gabriele, et al.
Publicado: (2022)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

The Human Gut Resistome up to Extreme Longevity
por: Tavella, Teresa, et al.
Publicado: (2021)

Exploring clade differentiation of the Faecalibacterium prausnitzii complex
por: Fabbrini, Marco, et al.
Publicado: (2022)

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
por: Gatti, Milo, et al.
Publicado: (2023)

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients
por: Gatti, Milo, et al.
Publicado: (2022)

Shotgun Metagenomics of Gut Microbiota in Humans with up to Extreme Longevity and the Increasing Role of Xenobiotic Degradation
por: Rampelli, Simone, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis in Childhood Vasculitis: A Perspective Comparative Pilot Study
por: Fabi, Marianna, et al.
Publicado: (2022)

Polyphenol and Tannin Nutraceuticals and Their Metabolites: How the Human Gut Microbiota Influences Their Properties
por: Fabbrini, Marco, et al.
Publicado: (2022)

HumanMycobiomeScan: a new bioinformatics tool for the characterization of the fungal fraction in metagenomic samples
por: Soverini, Matteo, et al.
Publicado: (2019)

Do the human gut metagenomic species possess the minimal set of core functionalities necessary for life?
por: Soverini, Matteo, et al.
Publicado: (2020)

G2S: A New Deep Learning Tool for Predicting Stool Microbiome Structure From Oral Microbiome Data
por: Rampelli, Simone, et al.
Publicado: (2021)

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
por: Rinaldi, Matteo, et al.
Publicado: (2021)

Effective Containment of a COVID-19 Subregional Outbreak in Italy Through Strict Quarantine and Rearrangement of Local Health Care Services
por: Tedeschi, Sara, et al.
Publicado: (2021)

Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation
por: D’Amico, Federica, et al.
Publicado: (2019)

The gut microbiome buffers dietary adaptation in Bronze Age domesticated dogs
por: Rampelli, Simone, et al.
Publicado: (2021)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Gut microbiota resilience and recovery after anticancer chemotherapy
por: Roggiani, Sara, et al.
Publicado: (2023)

ViromeScan: a new tool for metagenomic viral community profiling
por: Rampelli, Simone, et al.
Publicado: (2016)

Variation of Carbohydrate-Active Enzyme Patterns in the Gut Microbiota of Italian Healthy Subjects and Type 2 Diabetes Patients
por: Soverini, Matteo, et al.
Publicado: (2017)

Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis
por: Barone, Monica, et al.
Publicado: (2021)

Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT
por: Fabbrini, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gnst6if9or9fssaur8ed0iip2f